Skip to main content
$383.94 $6.85 (1.8%)

04:00 PM EDT on 05/07/21

Illumina Inc (NASDAQ:ILMN)

CAPS Rating: 4 out of 5

The Company is a developer, manufacturer and marketer of next-generation life-science tools and integrated systems for the analysis of genetic variation and biological function.

Current Price $383.94 Mkt Cap $56.1B
Open $379.76 P/E Ratio 89.43
Prev. Close $383.94 Div. (Yield) $0.00 (0.0%)
Daily Range $378.69 - $389.45 Volume 703,789
52-Wk Range $260.42 - $555.77 Avg. Daily Vol. 1,076,137

Caps

How do you think NASDAQ:ILMN will perform against the market?

Add Stock to CAPS Watchlist

All Players

1,299 Outperform
57 Underperform
 

All-Star Players

450 Outperform
6 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:ILMN Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

TMFTypeoh (95.47)
Submitted December 19, 2017

https://www.fool.com/investing/2017/12/05/why-illumina-jumped-98-in-november.aspx

XMFBlacknGoldX (< 20)
Submitted June 28, 2018

https://www.fool.com/investing/2018/06/22/illumina-might-be-overlooking-its-top-competitor-h.aspx

Recent Community Commentary

Read the most recent pitches from players about ILMN.

Recs

0
Member Avatar TMFjbonefish (47.66) Submitted: 5/5/2021 5:05:06 PM : Outperform Start Price: $375.93 NASDAQ:ILMN Score: +0.62

After 20 years, finally facing some competition. The good news for Illumina shareholders is that the market is expanding rapidly. The cheaper sequencing becomes, and the more technologies exist, the more use cases become available. The DNA sequencing industry is expected to grow from the current $8.4 billion to $40 billion over the next decade. That leaves room for a lot of winners. With dominant market share and two decades of innovation behind it, don't expect Illumina to stand still. For investors looking to ride the growth in genome sequencing, the largest, strongest horse with the best track record should be a smart addition to a portfolio.

Recs

0
Member Avatar CBK (41.27) Submitted: 4/23/2021 8:55:10 AM : Outperform Start Price: $410.93 NASDAQ:ILMN Score: -8.81

Finishing Walter Isaacson's The Code Breaker has made me believe that the next revolution that we are living in is the genomic revolution. Companies like Illumina, Editas, Crispr, Moderna, and Intellia are powering this revolution.

Recs

0
Member Avatar Hermanator (23.25) Submitted: 2/28/2021 6:56:48 PM : Outperform Start Price: $449.00 NASDAQ:ILMN Score: -23.96

Young innovative company

Leaderboard

Find the members with the highest scoring picks in ILMN.

Score Leader

OSUChad

OSUChad (94.90) Score: +2,313.49

The Score Leader is the player with the highest score across all their picks in ILMN.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
OSUChad 94.90 3/15/2007 Outperform 1Y $14.58 +2,534.24% +220.74% +2,313.49 0 Comment
dancon7 62.20 3/16/2007 Outperform 5Y $14.65 +2,521.65% +220.35% +2,301.29 0 Comment
fishman888 < 20 3/16/2007 Outperform 1Y $14.65 +2,521.65% +220.35% +2,301.29 0 Comment
dancesct 94.19 3/19/2007 Outperform 1Y $14.69 +2,513.61% +220.47% +2,293.15 1 Comment
oncmd 69.63 3/26/2007 Outperform 5Y $14.97 +2,465.59% +210.99% +2,254.60 0 Comment
25000THEVA 43.47 3/22/2007 Outperform NS $15.23 +2,420.95% +211.04% +2,209.91 0 Comment
mpaisis 36.16 4/13/2007 Outperform 3W $15.55 +2,369.86% +208.85% +2,161.01 1 Comment
redbellini < 20 3/6/2007 Outperform 3M $15.47 +2,381.84% +221.24% +2,160.60 0 Comment
NetscribeBiotech 87.76 3/12/2007 Outperform 1Y $15.73 +2,341.59% +219.08% +2,122.51 3 Comments
nachlat < 20 4/10/2007 Outperform 3Y $15.81 +2,328.46% +208.36% +2,120.11 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for ILMN.